Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in patients with newly diagnosed multiple myeloma who are ineligible for transplant
ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in...
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic...
ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients
ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients
ASH 2019: Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant
ASH 2019: Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant
ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma
ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma
ASH 2019: Novel off-the-shelf CAR NK product overcomes CD19 antigen escape in preclinical studies
ASH 2019: Novel off-the-shelf CAR NK product overcomes CD19 antigen escape in preclinical studies
ASH 2019: High response rate seen with BCMA-directed CAR T-cell therapy for multiple myeloma
ASH 2019: High response rate seen with BCMA-directed CAR T-cell therapy for multiple myeloma
ASH 2019: Encouraging results for dual-targeted CAR T-cell therapy in hard-to-treat multiple myeloma
ASH 2019: Encouraging results for dual-targeted CAR T-cell therapy in hard-to-treat multiple myeloma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation